Dysport abobotulinumtoxinA logo
Request a Rep

This site is intended for
US Healthcare Professionals.

Go to Patient Site

This site is intended for US Healthcare Professionals.

Go to Patient Site
Dysport abobotulinumtoxinA logo Dysport abobotulinumtoxinA logo
  • Home
  • HOME
  • SUPPORT & RESOURCES
  • INJECTOR LOCATOR
    FIND AN INJECTOR

     

    Find a Dysport injector in your area

     

    The Dysport Injector Locator is designed to make it easy for patients, caregivers, and referring physicians to find injectors in their area who are trained to administer botulinum toxins, including Dysport. If you think your patients may benefit from having a Dysport injection specialist on their care team, start your search today.

    Enter your information to find Dysport injectors in your area.

    City and State, or Zip

    The Dysport Injector Locator includes a list of healthcare providers compiled by Ipsen who are trained to administer botulinum toxin injections, including Dysport, for therapeutic use. The results shown may not be inclusive of all Dysport injectors in your area. SEE FULL DETAILS

    Please note: Although we update our directory regularly, this list may not have current provider information.

    No fees have been received by Ipsen or paid to the injector for their inclusion in this directory. Inclusion of an injector does not represent an endorsement by nor a recommendation from Ipsen regarding the qualifications of or medical care provided by the injectors nor implies that the injectors on the list will determine Dysport is the right treatment option.

    The selection of an injector is an important decision that should not be based solely on the inclusion in this directory. If you are an injector whose practice is currently being shown on the Dysport Injector Locator and you would like to opt out or update your profile information, please contact IpsenNADigital@ipsen.com.

    If you are an injector whose practice is not currently being shown on the Dysport Injector Locator and you would like to be included in appropriate search results, you can register here.

    REGISTER TO BE LISTED

     

    Add your practice or institution to our directory

     

    The Dysport Injector Locator is designed to make it easy for patients, caregivers, and referring physicians to find injectors in their area who are trained to administer botulinum toxins, including Dysport. If you or a member of your practice are a trained injector and would like to be included in our directory, register today.

    Enter your information (step 1 of 2)

    *Required

    The Dysport Injector Locator includes a list of healthcare providers compiled by Ipsen who are trained to administer botulinum toxin injections, including Dysport, for therapeutic use. SEE FULL DETAILS

    The Dysport Injector Locator includes a list of healthcare providers compiled by Ipsen who are trained to administer botulinum toxin injections, including Dysport, for therapeutic use. The results shown may not be inclusive of all Dysport injectors in your area. SEE FULL DETAILS

    Please note: Although we update our directory regularly, this list may not have current provider information.

    No fees have been received by Ipsen or paid to the injector for their inclusion in this directory. Inclusion of an injector does not represent an endorsement by nor a recommendation from Ipsen regarding the qualifications of or medical care provided by the injectors nor implies that the injectors on the list will determine Dysport is the right treatment option.

    The selection of an injector is an important decision that should not be based solely on the inclusion in this directory. If you are an injector whose practice is currently being shown on the Dysport Injector Locator and you would like to opt out or update your profile information, please contact IpsenNADigital@ipsen.com.

    If you are an injector whose practice is not currently being shown on the Dysport Injector Locator and you would like to be included in appropriate search results, you can register here.

    Learn more about Dysport injections

    Get Dysport Training
    See Dilution & Reconstitution See Dilution & Reconstitution See Dilution & Reconstitution
    See How to Order Dysport See How to Order Dysport See How to Order Dysport

    INDICATIONS

    DYSPORT (abobotulinumtoxinA) for injection is indicated for the treatment of:

    • spasticity in patients 2 years of age and older
    • cervical dystonia in adults

    IMPORTANT SAFETY INFORMATION

    Warning: Distant Spread of Toxin Effect

    Postmarketing reports indicate that the effects of DYSPORT and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses and in approved indications, cases of spread of effect have been reported at doses comparable to or lower than the maximum recommended total dose.

    Contraindications

    DYSPORT is contraindicated in patients with known hypersensitivity to any botulinum toxin products, cow’s milk protein, or to any of the components in the formulation, or infection at the proposed injection site(s). Serious hypersensitivity reactions including anaphylaxis, serum sickness, urticaria, soft tissue edema, and dyspnea have been reported. If such a serious reaction occurs, discontinue DYSPORT and institute appropriate medical therapy immediately.

    Warnings and Precautions

    Lack of Interchangeability Between Botulinum Toxin Products

    The potency Units of DYSPORT are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of DYSPORT cannot be compared to or converted into units of any other botulinum toxin products assessed with any other specific assay method.

    Dysphagia and Breathing Difficulties

    Treatment with DYSPORT and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or swallowing. When distant effects occur, additional respiratory muscles may be involved. Deaths as a complication of severe dysphagia have been reported after treatment with botulinum toxin. Dysphagia may persist for several weeks and require use of a feeding tube to maintain adequate nutrition and hydration. Aspiration may result from severe dysphagia and is a particular risk when treating patients in whom swallowing or respiratory function is already compromised. Treatment of cervical dystonia with botulinum toxins may weaken accessory muscles of ventilation, which may result in a critical loss of breathing capacity in patients with respiratory disorders who may have become dependent upon these muscles. Patients treated with botulinum toxin may require immediate medical attention should they develop problems with swallowing, speech, or respiratory disorders. These reactions can occur within hours to weeks after injection with botulinum toxin. 

    Pre-existing Neuromuscular Disorders

    Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (e.g., myasthenia gravis or Lambert-Eaton syndrome) should be monitored particularly closely when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including severe dysphagia and respiratory compromise from typical doses of DYSPORT.

    Human Albumin and Transmission of Viral Diseases

    This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, vCJD, or CJD have ever been identified for licensed albumin or albumin contained in other licensed products.

    Intradermal Immune Reaction

    The possibility of an immune reaction when injected intradermally is unknown. The safety of DYSPORT for the treatment of hyperhidrosis has not been established. DYSPORT is approved only for intramuscular injection.

    Pre-existing Conditions at the Injection Site

    Caution should be exercised when DYSPORT is used where the targeted muscle shows excessive weakness or atrophy.

    Adverse Reactions

    • The most common adverse reactions (≥4%) in adults with upper limb spasticity include muscular weakness; in adults with lower limb spasticity (≥5%) include falls, muscular weakness, and pain in extremity
    • The most common adverse reactions (≥10%) in pediatric patients with upper limb spasticity include upper respiratory tract infection and pharyngitis; in pediatric patients with lower limb spasticity include nasopharyngitis, cough, and pyrexia
    • The most common adverse reactions (≥5%) in adults with cervical dystonia include muscular weakness, dysphagia, dry mouth, injection site discomfort, fatigue, headache, musculoskeletal pain, dysphonia, injection site pain, and eye disorders

    Drug Interactions

    Co-administration of DYSPORT and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like agents) should only be performed with caution because the effect of the botulinum toxin may be potentiated. Use of anticholinergic drugs after administration of DYSPORT may potentiate systemic anticholinergic effects such as blurred vision. The effect of administering different botulinum neurotoxins at the same time or within several months of each other is unknown. Excessive weakness may be exacerbated by another administration of botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin. Excessive weakness may also be exaggerated by administration of a muscle relaxant before and after administration of DYSPORT.

    Please see full Prescribing Information, including BOXED WARNING.

     

    Ipsen Logo